What KOEHLER eClinical does

Data note: the firmographics block records KOEHLER eClinical as an 11–50 employee entity founded in 1991 in Freiburg, Germany, while the detailed source data describes Excelya, a private global CRO headquartered in Boulogne Billancourt, France. These profiles are internally inconsistent; the description below is anchored to the more substantive Excelya dataset.

Excelya is a privately held global Contract Research Organization (CRO) that operates a three-mode service architecture: Full Service, Functional Service Provider (FSP), and Clinical Resourcing. It serves Biotech, Pharma, and Medical Device organizations across six therapeutic areas — Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease & Vaccines, Pain Treatment & CNS, and Late Phase & Real-World Evidence. The company employs 1,000+ clinical research professionals across 16 offices in 25+ countries and has delivered 550+ clinical studies and 400+ clinical projects with a claimed 16% cost reduction.

The underlying technology stack centers on clinical operations and trial document management, with a best-in-class eTMF capability offering 100% digital trial document management and support for 3 of the 5 leading EDC systems. Integrated capabilities span Clinical Operations, Pharmacovigilance & Safety (24/7 drug safety monitoring), Data Management, eTMF Management, Medical Affairs (100+ experts, 100+ peer-reviewed publications), Statistics & Programming (150+ specialists, 25+ years of longest client partnerships in biometrics), Regulatory Affairs, and Quality Assurance. The company holds ISO 9001 and ISO 27001:2022 certifications, an EcoVadis Bronze sustainability rating, Veeva Services Partner status, and a 2025 French Government Gender Equality Index score of 97/100, reflecting enterprise-grade security, quality, and ESG positioning.

The revenue model is enterprise professional services and managed services under bespoke contracts; pricing is quote-based with no public disclosure. The go-to-market is direct enterprise field sales, anchored by long-duration engagements such as a 10-year pharmacovigilance partnership with UCB (announced 2026-05-26). Channels include industry conferences, case studies, press releases, and LinkedIn-led thought leadership. The firmographic record for KOEHLER eClinical (11–50 employees, founded 1991, Freiburg, Germany) is not corroborated by the detailed dataset and is treated here as a separate or stale record pending verification.

Name

KOEHLER eClinical

Legal name

Excelya Group

Website

https://koehler-eclinical.com

Company type

Private

Founded year

1991

Operating status

Operating

Headcount range

11–50 employees

Short description

KOEHLER eClinical per firmographics is a small German clinical research services provider; the substantive source data describes Excelya, a private global CRO delivering Full Service, FSP, and Resourcing solutions to biotech, pharma, and medical device sponsors across 25+ countries.

Ownership category

akta.pro rank

Product category

Clinical Research Services (CRO)

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical research services
• Contract research organization
• Pharmacovigilance services
• Clinical data management
• Regulatory affairs consulting

Headquarters

HQ city

Freiburg

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Full-Service CRO: Expert guidance for clinical trial success, operating as one team with clients from protocol design to final report delivery
2. Functional Service Provider (FSP): One-team approach where Excelya shares responsibility for client outcomes, keeping projects on track, on time, and on budget
3. Clinical Resourcing: Talent pool solutions providing clinical research operations professionals to fill client needs

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

KOEHLER eClinical provides clinical research services to the biopharmaceutical industry and life science organizations. Based on the available source material, the company operates within the contract research organization (CRO) space, offering full-service clinical trial support, functional service provider (FSP) engagements, and clinical resourcing solutions spanning clinical operations, pharmacovigilance, data management, eTMF management, biostatistics, regulatory affairs, and medical writing.

Product overview

Excelya is a global full-service Contract Research Organization (CRO) offering a unique business model with three service modes: Full Service, Functional Service Provider (FSP), and Clinical Resourcing. The company provides integrated capabilities including Clinical Operations, Pharmacovigilance & Safety, Data Management, eTMF Management, Medical Affairs, Statistics & Programming, Regulatory Affairs, and Quality Assurance. Excelya specializes across six therapeutic areas: Oncology & Hematology, Rare Disease & Pediatrics, Inflammation & Immunology, Infectious Disease & Vaccines, Pain Treatment & CNS, and Late Phase & Real-World Evidence. The integrated capabilities work together to support clients from protocol design to final report delivery.

Differentiator

Problem solved

Functional benefit

Products and services

• Full Service CRO End-to-end clinical trial management service delivering expert guidance from protocol design to final report, offered as a collaborative one-team model with clients for biotech, pharmaceutical, and medical device organizations.
• Functional Service Provider (FSP) FSP engagement model in which the provider shares responsibility for client outcomes, helping keep projects on track, on time, and on budget across functional areas of clinical development.
• Clinical Resourcing Talent-pool based resourcing service supplying clinical research operations professionals to fill client staffing needs across trials.

Quantifiable outcome

• 16% cost reduction on clinical projects
• +4 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• UCBcoreStrategic or Co-development Partner · 26 May 202610-year pharmacovigilance partnership between Excelya and UCB, demonstrating long-term strategic relationship in drug safety and pharmacovigilance services.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• PSI CRO: Full-service CRO with European roots delivering trials across oncology, hematology, rare disease and other specialties — closely comparable mid-market CRO profile and geographic orientation.
• Excelya: Global full-service CRO with 1,000+ experts across 25+ countries offering Full Service, FSP, and Resourcing solutions to biotech, pharma, and medical device clients — directly comparable service model and therapeutic coverage, though materially larger in scale than KOEHLER eClinical.
• KCR: European-headquartered mid-sized CRO providing clinical development and functional services across multiple therapeutic areas; similar niche positioning between global giants and small regional CROs that KOEHLER eClinical occupies.
• Cromsource: European CRO offering clinical research, staffing, and consulting services to pharma and biotech sponsors — comparable mid-market CRO with a similar mix of full-service and resourcing engagements.
• Worldwide Clinical Trials: Mid-sized global CRO focused on Phase II–III clinical development across CNS, cardiometabolic, oncology and rare disease; comparable therapeutic-area breadth and mid-market positioning.
• Ergomed: Specialist CRO with strong pharmacovigilance and rare disease focus; comparable European mid-market CRO profile and therapeutic specialization overlap.

Broad incumbents

• IQVIA: Largest global CRO with integrated R&D, technology, and data/analytics capabilities; relevant incumbent benchmark for the scale and platform breadth KOEHLER eClinical competes against.
• ICON plc: One of the world's largest CROs offering full-service, FSP, and laboratory services; relevant incumbent demonstrating the scale tier KOEHLER eClinical would need to reach to compete for top-tier sponsor work.
• Medpace: Established mid-to-large CRO with strong therapeutic-area specialization model; relevant incumbent comparable on service mix though materially larger and publicly listed.

Emerging players

• Clinipace Worldwide: Mid-sized technology-enabled CRO offering full-service clinical development; comparable to KOEHLER eClinical in emphasizing eClinical / technology-augmented delivery for smaller to mid-sized sponsors.

Market position

Strengths3 records

Weaknesses3 records

Competitive moat6 records

Key risks4 records

Key highlights4 records

Customer concentration

• YouTubeyoutube.com/@ExcelyaCRO
• Facebookfacebook.com/excelya.pharma/?ref=settings&qsefr=1
• LinkedInlinkedin.com/company/5122955
• Instagraminstagram.com/excelyapharma

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KOEHLER eClinical